MENU
AUTL
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Autolus Therapeutics (AUTL) Earnings Date & Reports

Industry: @Biotechnology
A.I. Advisor
published Earnings

AUTL is expected to report earnings to fall 34.52% to -20 cents per share on March 11

Autolus Therapeutics AUTL Stock Earnings Reports
Q4'24
Est.
$-0.20
Q3'24
Missed
by $0.10
Q2'24
Missed
by $0.03
Q1'24
Missed
by $0.16
Q4'23
Est.
$-0.44
The last earnings report on November 12 showed earnings per share of -31 cents, missing the estimate of -20 cents. With 2.58M shares outstanding, the current market capitalization sits at 800.94M.
View a ticker or compare two or three
AUTL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of cancer treatments

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
191 Wood Lane
Phone
+44 2038296230
Employees
471
Web
https://www.autolus.com